Literature DB >> 14570892

Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels.

Erwan Paitel1, Claire Sunyach, Cristine Alves da Costa, Jean-Christophe Bourdon, Bruno Vincent, Frédéric Checler.   

Abstract

We assessed the contribution of the cellular prion protein (PrPc) in the control of neuronal apoptosis by examining cell death in both human cells and murine primary cultured neurons. We first confirmed our previous finding that staurosporine-induced caspase activation is increased by PrPc overexpression in HEK293 cells. We show here that this phenotype is fully dependent on p53 and that the control of p53 activity by PrPc occurs at both transcriptional and post-transcriptional levels in human cells. Of most interest, we demonstrate that neuronal endogenous PrPc also controls a p53-dependent pro-apoptotic phenotype. Thus, DNA fragmentation and TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling)-positive cells were lower in primary cultured neurons derived from Zrch-1 mice embryos in which PrPc has been abrogated than in wild-type neurons. PrPc knock-out neurons also displayed drastically diminished caspase-3-like activity and immunoreactivity together with reduced p53 expression and transcriptional activity, a phenotype complemented in part by PrPc transfection. Interestingly, p53 expression was also reduced in the brain of adult Prnp-/- mice. Neuronal PrPc likely controls p53 at a post-transcriptional level because the deletion of cellular prion protein is accompanied by a higher Mdm2-like immunoreactivity and reduced phosphorylated p38 MAPK expression. We therefore propose that the physiological function of endogenous cellular prion could be to regulate p53-dependent caspase-3-mediated neuronal cell death. This phenotype likely occurs through up-regulation of p53 promoter transactivation as well as downstream by controlling p53 stability via Mdm2 expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14570892     DOI: 10.1074/jbc.M310453200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Two-steps control of cellular prion physiology by the extracellular regulated kinase-1 (ERK1).

Authors:  Frédéric Checler
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

2.  Lethal recessive myelin toxicity of prion protein lacking its central domain.

Authors:  Frank Baumann; Markus Tolnay; Christine Brabeck; Jens Pahnke; Ulrich Kloz; Hartmut H Niemann; Mathias Heikenwalder; Thomas Rülicke; Alexander Bürkle; Adriano Aguzzi
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

3.  The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo.

Authors:  Marie-Victoire Guillot-Sestier; Claire Sunyach; Charlotte Druon; Sabine Scarzello; Frédéric Checler
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

4.  The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein.

Authors:  Moustapha Cissé; Eric Duplan; Marie-Victoire Guillot-Sestier; Joaquim Rumigny; Charlotte Bauer; Gilles Pagès; Hans-Dieter Orzechowski; Barbara E Slack; Frédéric Checler; Bruno Vincent
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

5.  Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.

Authors:  Jingjing Liang; Wei Wang; Debra Sorensen; Sarah Medina; Sergei Ilchenko; Janna Kiselar; Witold K Surewicz; Stephanie A Booth; Qingzhong Kong
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

6.  Proteolytic processing of the prion protein in health and disease.

Authors:  Hermann C Altmeppen; Berta Puig; Frank Dohler; Dana K Thurm; Clemens Falker; Susanne Krasemann; Markus Glatzel
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

7.  α-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid β (Aβ)-associated cell death.

Authors:  Marie-Victoire Guillot-Sestier; Claire Sunyach; Sergio T Ferreira; Maria-Paz Marzolo; Charlotte Bauer; Aurélie Thevenet; Frédéric Checler
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

8.  Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death.

Authors:  Christopher J Choi; Vellareddy Anantharam; Nathan J Saetveit; Robert S Houk; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2007-05-04       Impact factor: 4.849

Review 9.  The cellular prion protein (PrP(C)): its physiological function and role in disease.

Authors:  Laura Westergard; Heather M Christensen; David A Harris
Journal:  Biochim Biophys Acta       Date:  2007-03-02

10.  Examining the Neural and Astroglial Protective Effects of Cellular Prion Protein Expression and Cell Death Protease Inhibition in Mouse Cerebrocortical Mixed Cultures.

Authors:  Kevin K W Wang; Zhihui Yang; Allen Chiu; Fan Lin; Richard Rubenstein
Journal:  Mol Neurobiol       Date:  2015-09-04       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.